Exscientia plc (EXAI) Stock Analysis
DELISTED
What happened to Exscientia plc (EXAI) stock?
Exscientia plc (EXAI) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $633M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Exscientia plc (EXAI). Exscientia plc is an AI-driven pharmatech company focused on discovering and developing small molecule drugs. Their platform integrates AI across target identification, drug design, and patient selection to accelerate drug development.
Last analyzed: Mar 16, 2026Exscientia plc (EXAI) Healthcare & Pipeline Overview
Exscientia plc ADR Information Sponsored
Exscientia plc (EXAI) trades in the U.S. as an American Depositary Receipt (ADR).
- ADR Level: 2
- ADR Ratio: 1:1
More about this archive record
Can I still buy EXAI shares?
No. EXAI stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for EXAI elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before EXAI stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Exscientia plc. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.